Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps

Abstract

With the ongoing need to improve therapy for non-small cell lung cancer (NSCLC) there has been increasing interest in developing reliable preclinical models to test novel therapeutics. Patient-derived tumor xenografts (PDX) are considered to be interesting candidates. However, the establishment of such model systems requires highly specialized research… (More)
DOI: 10.1002/cam4.357

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Ilie2015SettingUA, title={Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps}, author={Marius Ilie and Manoel Nunes and Lydia Blot and V{\'e}ronique J Hofman and Elodie Long-Mira and Catherine Butori and Eric Selva and Ana Merino-Trigo and Nicolas V{\'e}nissac and J er{\^o}me Mouroux and Patricia Vrignaud and Paul Hofman}, booktitle={Cancer medicine}, year={2015} }